News

PreserVision is the #1 doctor-recommended eye vitamin brand specially formulated for people with moderate to advanced Age-Related Macular Degeneration. The 2-in-1 formula helps make it simpler for consumers

Proceeds from the financing will be used to advance the selection and development of lead molecules designed to modify the pathobiology of fibrotic diseases. The round included new

"In response to the growing demand for Immuno-Oncology translational services, CrownBio is now able to offer at its local facilities immunophenotyping analysis, including multi-color flow cytometry, immunohistochemistry and

As previously announced, Perrigo can launch a generic version of Ofirmev (acetaminophen) injection on December 6, 2020, or earlier under certain circumstances. In addition, Perrigo has secured the

The approval, including in the UK, Germany and Spain, is for the biosimilarity study part of the phase 3 program, which is designed to allow interchangeability with Humira

The study demonstrated that Keytruda was superior to chemotherapy as measured by progression-free survival (PFS) and overall survival (OS). Based on the positive results, the independent data monitoring

The five-story, 175,000-square-foot addition to Pfizer’s Andover campus is expected to be completed in January 2019. The facility will house about 75 employees who will produce vaccines and

The randomized, controlled, blinded, cross-over study is designed to evaluate the safety and efficacy of FLX-787, the Company’s single molecule, chemically synthesized, transient receptor potential (TRP) ion channel

If approved, Carbylan will be renamed KalVista Pharmaceuticals, Inc. The transaction has been unanimously approved by the boards of directors of both companies. Carbylan’s three largest shareholders, InterWest